Clinical Trials Sponsored by Stallergenes laboratories

Total 2244 results

Stallergenes Greer

Active, not recruiting

Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma (YOBI)

Allergic Rhinoconjunctivitis | Birch Pollen Allergy

Germany
Stallergenes Greer

Completed

Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis

Allergy

Germany
Stallergenes Greer

Completed

Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets

Allergy

France
Stallergenes Greer

Completed

A Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Asthmatic Patients Allergic to House-dust Mites

Allergy

China
Stallergenes Greer

Completed

Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts

Asthma | House Dust Mite Allergy

France
Stallergenes Greer

Terminated

Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children

Allergic Rhinitis Due to Dust Mite
Stallergenes Greer

Terminated

Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients

Allergy

France
Stallergenes Greer

Completed

Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR

Rhinitis, Allergic, Perennial | House Dust Mite Allergy

France, United States
Stallergenes Greer

Completed

Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis

Primary Disease

France, Italy, Spain
Stallergenes Greer

Completed

Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis

Allergy
Stallergenes Greer

Completed

Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract

Seasonal Allergic Rhinitis

Austria
Stallergenes Greer

Completed

Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis

Allergic Rhinitis
Stallergenes Greer

Completed

Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis

Allergic Rhinitis Due to Grass Pollens

United States
Stallergenes Greer

Completed

Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma

Asthma | House Dust Mite Allergy

France, Germany, Poland
Stallergenes Greer

Completed

Sensitivity and Specificity of 3 Solutions of Allergen Extract for Diagnosis by Skin Prick Testing

Allergy
Stallergenes Greer

Completed

Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite (HDM) Tablets in Allergic Rhinitis Environment Exposure Chamber Model

House Dust Mites Allergic Rhinitis

Canada
Stallergenes Greer
Registrat-Mapi

Terminated

International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis (ALTO)

Allergic Rhinitis Due to Grass Pollens

France
Stallergenes Greer
Syneos Health

Completed

Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents

House Dust Mite Allergic Rhinitis

Canada
Stallergenes Greer
Quintiles, Inc.

Completed

Safety and Tolerability Study of rBet v1 SLIT Tablets

Rhinitis, Allergic, Seasonal | Birch Pollen-Related Rhinoconjunctivitis

Denmark
Stallergenes Greer
Quintiles, Inc.

Completed

Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1

Rhinitis, Allergic, Seasonal | Birch Pollen-Related Rhinoconjunctivitis

Denmark
Stallergenes Greer
Quintiles, Inc.

Completed

Safety and Tolerability Study of Ragweed SLIT Tablets

Rhinitis, Allergic, Seasonal | Ragweed Pollen Allergy

Hungary
Stallergenes Greer
Monitoring Force Group

Completed

Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma (PROTECT)

Allergy
Stallergenes Greer
Venn Life Sciences

Completed

Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis

Allergy

Germany
Stallergenes Greer
Quintiles, Inc.; Aptuit

Completed

Study of rBet v1 Tablets

Rhinitis, Allergic, Seasonal | Birch Pollen-related Rhinoconjunctivitis

Denmark, Finland, France, Poland, Germany, Lithuania, Russian Federation, Sweden
Assistance Publique - Hôpitaux de Paris
French Society of Allergology; Stallergenes laboratories; Picot-Lactalis laboratory and other collaborators

Completed

Impact of the Therapeutic Education on the Quality of Life of the Child Suffering of Food Allergy IgE-mediated (EducAA)

IgE Mediated Food Allergy

France
Laboratorios Viñas, S.A.
Hospital Vall d'Hebron; Laboratorio Echevarne

Completed

Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) (MELATOZINC)

Fatigue Syndrome, Chronic | Myalgic Encephalomyelitis

Spain
Laboratorios Viñas, S.A.
Hospital Vall d'Hebron; Laboratorio Echevarne

Recruiting

Melatonin and Zinc Administration on Cardinal Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MelatoZincME)

Chronic Fatigue Syndrome | Myalgic Encephalomyelitis

Spain
Forest Laboratories
Mylan Laboratories

Terminated

Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-release (ER) for Hypertension

Hypertension

United States
bioLytical Laboratories

Recruiting

Trial of Hepatitis C Self-Testing in the Hands of Untrained Lay Users

Hepatitis C

South Africa
Braintree Laboratories

Recruiting

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis

Erosive Esophagitis

United States
United Laboratories

Recruiting

Lactoferrin + Vitamin E + Zinc for Hormonal Acne

Hormonal Acne

Philippines
Winston Laboratories

Not yet recruiting

Civamide Nasal Solution for Cluster Headache (ECH)

Episodic Cluster Headache
Braintree Laboratories

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease

Non-erosive Reflux Disease

United States
Braintree Laboratories

Completed

A Safety Study of 3 Different Bowel Cleansing Preparations

Endoscopy | Colonoscopy | Bowel Preparation

United States
Braintree Laboratories

Completed

A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects

Colonoscopy

United States
Braintree Laboratories

Completed

A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to Colonoscopy

Colonoscopy

United States
Braintree Laboratories

Completed

A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

Colonoscopy

United States
bioLytical Laboratories

Completed

Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection

HIV Infections

United States
Forest Laboratories

Completed

A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically (LIN-PK-01)

Irritable Bowel Syndrome | Constipation | Breast Feeding

United States
Forest Laboratories

Completed

Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder

Generalized Anxiety Disorder

United States
Forest Laboratories

Completed

Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States
United Laboratories

Unknown

SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS

Tinea Pedis

Philippines
Forest Laboratories

Completed

Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine

Autistic Disorder | Autism | Autism Spectrum Disorders | Asperger Syndrome | Asperger's Disorder | Pervasive Developmental Disorder - Not Otherwise Specified (PDD-NOS)

United States, Belgium, Colombia, Estonia, France, Hungary, Iceland, Italy, Korea, Republic of, New Zealand, Poland, Serbia, South Africa, Spain, Ukraine
Forest Laboratories

Completed

Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder

Depression | Bipolar Disorder

United States, Bulgaria, Serbia, Ukraine, Croatia, Romania, Puerto Rico, Slovakia
Forest Laboratories

Completed

Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression

Depression | Bipolar Disorder

United States, Bulgaria, Poland, Puerto Rico, Lithuania, Estonia
Forest Laboratories

Completed

A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder

Depressive Disorder, Major

United States
Braintree Laboratories

Completed

A Pilot Study of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation

Constipation

United States
Forest Laboratories

Completed

Diafert for Embryo Selection and Fertility Improvement (DESTINy)

Infertility

Belgium
Forest Laboratories

Completed

Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States
Forest Laboratories

Completed

Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections (cSSSI)

Bacterial Infections

Argentina, Chile, Mexico, Russian Federation, United States, Poland, Germany, Brazil, Peru, Romania, Ukraine

3

Subscribe